Share

FDA Approves First Treatment for Thyroid Eye Disease

In January, Endocrine News reported on the possible upcoming availability of teprotumumab as a promising treatment for of thyroid eye disease (TED), a serious, progressive and vision-threatening rare autoimmune disease that is associated with proptosis (eye bulging), diplopia (double vision), blurred vision, pain, inflammation, and facial disfigurement. Up to 50% of patients with Graves’ disease...
Share

Endocrine Society Urges Policy Makers to Follow Science on Transgender Health

Texas custody case prompts unfounded claims. A custody case in Texas has sparked heated debate and embroiled state policy makers in public discussions about the diagnosis and appropriate medical treatment of transgender children. Unfortunately, many of the claims being made about gender-affirming care for transgender and gender-incongruent individuals are inaccurate. Policies concerning the diagnosis and...